Drug intelligence / Profile preview

Fel-O-Vax

Development stage
Unknown
Lead developer
Elanco
Modality
Vaccines & Immunotherapeutics
Administration
Subcutaneous, Intramuscular
01

Overview

Fel-O-Vax is a brand name for a series of killed virus vaccines primarily used in veterinary medicine to protect healthy cats against feline infectious diseases. Specific formulations target feline leukemia virus (FeLV), feline rhinotracheitis virus (FHV-1), feline calicivirus (FCV), feline panleukopenia virus (FPV), and sometimes Chlamydia felis or other pathogens, administered subcutaneously to cats 8-10 weeks of age or older as part of primary vaccination series with boosters. Developed and manufactured by Elanco (following acquisition from Boehringer Ingelheim), these inactivated vaccines stimulate humoral immunity without viral replication, aiding in disease prevention in high-risk environments like multi-cat households or shelters.[1][3][4][5][6][16]

Brand names
Fel-O-Vax
Other names
TruFel
02

Targets

FPV (Feline panleukopenia virus)

Beyond the preview

Go deeper on Fel-O-Vax.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Fel-O-Vax.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call